Всего подписок: 2, всего просмотров: 1185
Оценка читателей: голосов 0
1. Barrett A. J., Battiwalla M. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol 2010, 3, 429–441.
2. Birnbaum M. E., Mendoza J. L., Sethi D. K., Dong S., Glanville J., Dobbins J., Özkan E., Davis M. M., Wucherpfennig K. W., Garcia K. C. Deconstructing the peptide- MHC specifi city of T cell recognition. Cell 2014, 157, 1073–1087.
3. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest 1968, Suppl 97, 77–89.
4. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., Gluckman J. C. Diff erentiation of human dendritic cells from monocytes in vitro. European Journal of Immunology 1997, 27, 431–441.
5. Dash P., Fiore-Gartland A. J., Hertz T., Wang G. C., Sharma S., Souquette A., Crawford J. C., Clemens E. B., Nguyen T. H.O., Kedzierska K. Quantifi able predictive features defi ne epitope-specifi c T cell receptor repertoires. Nature 2017, 547, 89.
6. den Haan J. M., Sherman N. E., Blokland E., Huczko E., Koning F., Drij fhout J. W., Skipper J., Shabanowitz J., Hunt D. F., Engelhard V. H., and et al. Identifi cation of a graft versus host disease-associated human minor histocompatibility antigen. Science 1995, 268, 1476–1480.
7. Glanville J., Huang H., Nau A., Hatton O., Wagar L. E., Rubelt F., Ji X., Han A., Krams S. M., Pettus C., et al. Identifying specifi city groups in the T cell receptor repertoire. Nature 2017, 547, 94–98.
8. Heemskerk M.H., Hoogeboom M., de Paus R. A., Kester M. G., van der Hoorn M. A., Goulmy E., Willemze R., Falkenburg J. H. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specifi c T-cell receptor complexes expressing a conserved alpha joining region. Blood 2003, 102, 3530–3540.
9. Heemskerk M. H., Hoogeboom M., Hagedoorn R., Kester M. G., Willemze R., Falkenburg J. H. Reprogramming of virus-specifi c T cells into leukemia-reactive T cells using T cell receptor gene transfer. J Exp Med 2004, 199, 885–894.
10. Hobo W., Broen K., van der Velden W. J., Greupink-Draaisma A., Adisty N., Wouters Y., Kester M., Fredrix H., Jansen J. H., van der Reij den B., et al. Association of disparities in known minor histocompatibility antigens with relapse-free survival and graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2013, 19, 274–282.
11. Li H. M., Hiroi T., Zhang Y., Shi A., Chen G., De S., Metter E. J., Wood W. H., Sharov A., Milner J. D., et al. TCRβ repertoire of CD4(+) and CD8(+) T cells is distinct in richness, distribution, and CDR3 amino acid composition. Journal of Leukocyte Biology 2016, 99, 505–513.
12. Madi A., Poran A. T cell receptor repertoires of mice and humans are clustered in similarity networks around conserved public CDR3 sequences. 2017, 6.
13. Mamedov I. Z., Britanova O. V., Zvyagin I. V., Turchaninova M. A., Bolotin D. A., Putintseva E. V., Lebedev Y. B., Chudakov D. M. Preparing unbiased T-cell receptor and antibody cDNA libraries for the deep next generation sequencing profi ling. Front Immunol 2013, 4, 456.
14. Meij P., Jedema I., van der Hoorn M. A., Bongaerts R., Cox L., Wafelman A. R., Marij t E. W., Willemze R., Falkenburg J. H. Generation and administration of HA-1- specifi c T-cell lines for the treatment of patients with relapsed leukemia after allogeneic stem cell transplantation: a pilot study. Haematologica 2012, 97, 1205–1208.
15. Toebes M., Rodenko B., Ovaa H., Schumacher T. N. Generation of peptide MHC class I monomers and multimers through ligand exchange. Curr Protoc Immunol 2009, Chapter 18, Unit 18 16.
16. van Bergen C. A., van Luxemburg-Heij s S. A., de Wreede L. C., Eefting M., von dem Borne P. A., van Balen P., Heemskerk M. H., Mulder A., Claas F. H., Navarrete M. A., et al. Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T cell response. J Clin Invest 2017, 127, 517–529.
17. Vdovin A. S., Postovskaya A. M., Bykova N. A., Romaniuk D. S., Alieva A. K., Yefi mova P. R., Sheetikov S. A., Julhakyan H. L., Efi mov G. A. Comparative analysis of minor histocompatibility antigens genotyping methods. Oncohematology 2016, 11, 40–50.
18. Warren E.H., Fujii N., Akatsuka Y., Chaney C. N., Mito J. K., Loeb K. R., Gooley T. A., Brown M. L., Koo K. K., Rosinski K. V., et al. Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specifi c for minor histocompatibility antigens. Blood 2010, 115, 3869–3878.
19. Wolfl M., Greenberg P. D. Antigen-specifi c activation and cytokine-facilitated expansion of naive, human CD8+ T cells. Nat Protoc 2014, 9, 950–966.
20. Wolfl M., Kuball J., Ho W. Y., Nguyen H., Manley T. J., Bleakley M., Greenberg P. D. Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8(+) T cells responding to antigen without requiring knowledge of epitope specifi cities. Blood 2007, 110, 201–210.
21. Zvyagin I.V., Pogorelyy M. V., Ivanova M. E., Komech E. A., Shugay M., Bolotin D. A., Shelenkov A. A., Kurnosov A. A., Staroverov D. B., Chudakov D. M., et al. Distinctive properties of identical twins’ TCR repertoires revealed by high-throughput sequencing. Proceedings of the National Academy of Sciences of the United States of America 2014, 111, 5980–5985.